GPR35 agonist 3

Overview

GPR35 agonist 3 is a synthetic GPR35 agonist with an EC 50 value of 1.4 μM. GPR35 agonist 3 can be used for the research of various diseases, such as gastric cancer , type 2 diabetes, cardiovascular diseases, immune system and peripheral nervous system.

Application

Products | Products > Disease Areas > Gastric Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > GPR35

Product Information

• Catalog No.: HY-131728
• CAS No.: 123021-85-2
• Molecular Formula: C12H9NO5S
• Molecular Weight: 279.27
• Purity: 98.32%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Availability: In-stock

Source

Original product source